Implantable cardioverter defibrillator in MC Ljubljana. An overview from 1989–2005

Authors

  • Igor Zupan
  • Peter Rakovec
  • Jerneja Tasič
  • Borut Geršak
  • Tone Gabrijelčič

Keywords:

implantable defibrillator, ventricular fibrillation, ventricular tachycardia

Abstract

Abstract: It is now a scientifically proven fact that implantable cardioverter defibrillator (ICD) therapy is the therapy of first choice for patients at high risk of life-threatening ventricular tachyarrhythmias. A significant contribution to the accelerating acceptance of ICD therapy comes from the technological advances, which have reduced the morbidity and enhanced programming and diagnostics very similar to pacemaker therapy. In Medical Centre Ljubljana ICDs have been implanted since 1989, altogether 207 pieces in 153 patients. We evaluated the indications, pacing mode, ejection fraction, number of shocks and the concomitant pharmacological treatment.

Downloads

Download data is not yet available.

References

Zipes DP, Wellens HJ. Sudden cardiac death. Circulation 1998; 98: 2334– 51.

Arnsdorf MF, Kopp DE. General principles of implantable cardioverter defibrillator. In: Rose BD. UpToDate. Wellesley, MA: UpToDate; 2001.

Bigger JT. Expanding indications for implantable cardiac defibrillators. N Engl J Med 2002; 346: 931–2.

Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877–83.

Kadish A. Prophylactic defibrillator implantation-toward an evidence based approach. N Engl J Med 2005; 352: 285–7.

Gillis AM. Prophylactic implantable cardioverter-defibrillators after myocardial infarction-not for everyone. N Engl J Med 2004; 351: 2540–2.

Brady GH, Lee KL, Mark DB, Poole JE, et al. Amiodarone or an implantable cardioverter defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225–37.

Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the dual chamber and VVI implantable defibrilator (DAVID) trial. JAMA 2002; 288: 3115– 23.

A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee on Pacemaker Implantation). ACC/AHA/NASPE guidelines for implantation of cardiac pacemakers and antiarrythmia devices: Indications for ICD therapy. In: Rose BD. UpToDate. Wellesley, MA: UpToDate; 2002.

Issue

Section

Test Section

How to Cite

1.
Implantable cardioverter defibrillator in MC Ljubljana. An overview from 1989–2005. ZdravVestn [Internet]. 2005 Dec. 29 [cited 2024 Nov. 2];74. Available from: https://vestnik.szd.si/index.php/ZdravVest/article/view/2179

Most read articles by the same author(s)

1 2 > >>